|
|
| 產(chǎn)品基本信息 |
|
| 產(chǎn)品編號：E509003 |
| 產(chǎn)品名稱：Elvitegravir-d5 |
| 產(chǎn)品CAS：1131640-69-1 |
| 規(guī)格含量：2.5mg |
| 產(chǎn)品價(jià)格：面議 |
| 聯(lián)系我們: |
 |
|
 |
|
|
| 產(chǎn)品詳細(xì)介紹 |
| 標(biāo)準(zhǔn)品編號: |
E509003 |
| 名稱: |
Elvitegravir-d5 |
| 別名: |
6-[(3-Chloro-2-fluorophenyl)methyl]-1,4-dihydro-1-[(1S)-1-(hydroxymethyl-d2)-2-methylpropyl]-7-(methoxy-d3)-4-oxo-3-quinolinecarboxylic Acid |
| CAS號: |
1131640-69-1 |
| 分子式: |
C??H??D?ClFNO? |
| 分子量: |
452.91 |
| 種類: |
Standards; Enzyme Activators and Inhibitors; Pharmaceutical/API Drug Impurities/Metabolites; |
| 應(yīng)用: |
Elvitegravir-d5, is the laballed analogue of Elvitegravir (E509000), a novel inhibitor of human immunodeficiency virus type 1 integrase. |
| 參考文獻(xiàn) |
|
|
|
|
?您的位置：
